
Sign up to save your podcasts
Or
Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts
4
44 ratings
Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts
11,833 Listeners
120 Listeners
165 Listeners
47,886 Listeners